Q-Line Biotech Ltd

NSE: QLINE · Healthcare · 6 announcements

Share price: ₹668.45
Market cap: ₹1,559 Cr
Revenue (annual): ₹341.7 Cr
Net profit (annual): ₹55.72 Cr
P/E (TTM): 28.0×Sector 57.8×
Promoter holding: 67.51%
FII holding: 1.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Partnership 1 Other Announcement 1 Financial Results 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

2 Sep 2026 17:54 IST NSE

PartnershipAlfa Alert

Q-Line Biotech Partnership

Q-Line Biotech amended its license agreement with Boule Medical AB, Sweden. The revision includes a 25% reduction in license/royalty costs effective from July 2026.

From: Boule Medical AB
Execution: 5 years

Read the filing ↗